Return To Phacilitate
  • When 7-9 September, 2026
  • Where InterContinental Barcelona
  • Search
Sponsorship Opportunities Pre-Register
SEARCH

What's In Store For You? 

Advanced Therapies Europe 2026 offers a unique opportunity for academics working in cell and gene therapy to connect with biotech leaders, pharma, regulators, and investors — the full ecosystem needed to turn early-stage science into patient-ready solutions.

Whether you're seeking industry partnerships, insight into regulatory pathways, or funding opportunities, this is your platform to move your research forward.

✅ 996 pre-arranged meetings.
✅ $1bn+ in investor capital.
✅ Curated 1:1 partnering designed for outcomes.

Contact Nana Agyekum for a tailored package

Scientific innovation alone is no longer enough—early proof of commercial viability is now essential

The environment for CGT start-ups is more demanding than ever. Breakthrough science alone is not enough—success depends on demonstrating clinical relevance, scalability, and a credible path to market early on. Building with the end in mind is now essential.

  • Investors expect early evidence of differentiation and commercial viability
  • Strategic partnerships are key to accessing expertise, infrastructure, and capital
  • Operational readiness, including manufacturing and regulatory planning, is a core value driver

Discover Advanced Therapies Europe as a start up

See how Advanced Therapies Europe helps startups gain traction, secure funding, and accelerate go-to-market strategies. Whether you're preparing for your next raise, looking to connect with investors, or need insights into regulatory and manufacturing pathways — this is the event built for ambitious CGT ventures like yours.

Content Packed Agenda

Gain insights, meet investors, and accelerate your path to commercialization.

State of the Art Networking

Discover promising companies, network with peers, and explore new opportunities.

Unlock Funding Opportunities

Meet funders and explore translational grants designed to move your research from lab to clinic.

Shape the Future of CGT

Join discussions on the critical role of academia in driving early-stage innovation and equitable access.

Apply to attend ATE as a Start-up:

Key themes to discover...

  • Visibility with the right audience - Get in front of investors, pharma and partners actively looking for opportunities. A curated audience ensures your time is spent with people who matter
  • Securing early-stage funding - Meet investors who are still deploying capital. Understand what they need to see and position your story to move beyond first conversations.
  • Turning ambition into execution - Move beyond great science. Gain practical insight and connections to help you execute, secure funding and progress toward clinical and commercial milestones.
  • Learning what drives success now - Hear from founders and investors on what works in today’s market. Avoid common pitfalls and accelerate your path forward.
  • Building the right partnerships early - Connect with pharma, CDMOs and advisors who can support your development. Identify and secure relationships that will shape your trajectory.

View the agenda

Put Your Science in Front of the Right People

If you’re building momentum toward funding, partnerships, or clinical milestones, this is your opportunity to connect with the stakeholders who can move you forward.

The Delegate Pack shows you exactly who you’ll meet and how to maximise those interactions.

Inside the delegate pack:

  • A list of active investors and pharma companies looking for new opportunities
  • Insight into what partners are prioritising right now
  • How the 1:1 meeting concierge helps you secure relevant conversations
  • Agenda highlights to help you position your story effectively

Download the Delegate Pack

Who Might You Find On the Show Floor?

2025 Attendee List 2025 Exhibitor List

600+
Attendees
40+
Companies
90+
Speakers
170+
Therapeutic Developers

 

  • "What an incredible few days at the ATE conference by Phacilitate! Grateful for the power of my network and the opportunity to meet so many familiar faces while growing it further.”
    Head of Business Development: Cell Therapy and Laboratory Services | Cell and Gene Therapy
  • “Impactful moments and connections.”
    Director Global Cell and Gene Therapies Portfolio Management | EMBA | Deep Tech
  • “Already having fantastic conversations here at ATE24 in Lisbon.”
    Experienced Leader in Cell and Gene Therapy Business and Commercial Strategy
Search